These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine. Zarrindast MR; Poursoltan M Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110 [TBL] [Abstract][Full Text] [Related]
43. Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154). Di Chiara G; Porceddu ML; Vargiu L; Gessa GL Pharmacology; 1978; 16 Suppl 1():135-42. PubMed ID: 643899 [TBL] [Abstract][Full Text] [Related]
44. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease. Koller WC; Herbster G Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789 [TBL] [Abstract][Full Text] [Related]
45. Time course of dopaminergic hypersensitivity following chronic narcotic treatment. Carlson KR; Almasi J Pharmacol Biochem Behav; 1979 Sep; 11(3):283-7. PubMed ID: 574284 [TBL] [Abstract][Full Text] [Related]
46. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain. Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860 [TBL] [Abstract][Full Text] [Related]
47. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats]. Minematsu N Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718 [TBL] [Abstract][Full Text] [Related]
49. Sensitivity to apomorphine in the guinea pig as a function of age and body weight. Carlson KR; Almasi J Psychopharmacology (Berl); 1978 May; 57(3):279-82. PubMed ID: 97709 [TBL] [Abstract][Full Text] [Related]
50. Enhanced stereotypies after repeated injections but not continuous amphetamines. Nelson LR; Ellison G Neuropharmacology; 1978 Dec; 17(12):1081-4. PubMed ID: 570650 [No Abstract] [Full Text] [Related]
57. The stress-dependent nature of apomorphine hyperthermia. Snow AE; Horita A Brain Res; 1976 Nov; 117(1):163-8. PubMed ID: 1033021 [No Abstract] [Full Text] [Related]
58. Initial bromocriptine did not change mortality in early, mild Parkinson disease. Albanese A ACP J Club; 2002; 136(3):109. PubMed ID: 11985450 [No Abstract] [Full Text] [Related]
59. Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin. Hoffman DC; Wise RA Psychopharmacology (Berl); 1993; 110(4):402-8. PubMed ID: 7870909 [TBL] [Abstract][Full Text] [Related]
60. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy. Globus M; Bannet J; Lerer B; Belmaker RH Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]